Evaluation of ceruloplasmin levels in patients undergoing surgical interventions with nasal polyps

Auris Nasus Larynx

Volumn 40, Issue 3, 2013, Pages 282-285

  Bozkus, Ferhat ^a   Ulas, Turgay ^a   San, Imran ^a   Yesilova, Yavuz ^a   Iynen, Ismail ^a   Guldur, Muhammed Emin ^a   Aksoy, Nurten ^a  

^a HARRAN UNIVERSITY   (Turkey)

Author keywords

Ceruloplasmin; Concha hypertrophy; Nasal polyp; Oxidative stress; Septal deviation

Indexed keywords

ACUTE PHASE PROTEIN; CERULOPLASMIN; REACTIVE OXYGEN METABOLITE;

ADULT; ARTICLE; BLOOD SAMPLING; CHEMICAL ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENDOSCOPIC SURGERY; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; NOSE SEPTUM; NOSE SEPTUM RECONSTRUCTION; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; SURGICAL TECHNIQUE;

ADULT; CERULOPLASMIN; CROSS-SECTIONAL STUDIES; ENDOSCOPY; FEMALE; HUMANS; HYPERTROPHY; MALE; NASAL POLYPS; NASAL SEPTUM; TURBINATES;

EID: 84875805815     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2012.07.018     Document Type: Article

References (41)

1. Watkins D.N., Lewis R.H., Basclain K.A., Fisher P.H., Peroni D.J., Garlepp M.J., et al. Expression and localization of the inducible isoform of nitric oxide synthase in nasal polyp epithelium. Clin Exp Allergy 1998, 28:211-219.
2. Sarisoy B.A., Eken M., Oktay A.Z., Paksoy M., Sanli A. Myeloperoxydase expression in the pathogenesis of nasal polyps. Indian J Otolaryngol Head Neck Surg 2011, 63:260-263.
3. Bachert C., Gevaert P., Holtappels G., Cuvelier C., van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000, 14:279-290.
4. Norlander T., Brönnegård M., Stierna P. The relationship of nasal polyps, infection, and inflammation. Am J Rhinol 1999, 13:349-355.
5. Nelson H.S. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 2004, 113:635-642.
6. Shukla G.K., Mahajan A., Pandey S., Gujrati V.R., Vrat S., Mishra S.C., et al. A study of free radicals and scavenging enzyme in tonsillitis. Boll Chim Farm 1996, 135:653-655.
7. Dogru H., Delibaş N., Döner F., Tüz M., Uygur K. Free radical damage in nasal polyp tissue. Otolaryngol Head Neck Surg 2001, 124:570-572.
8. Döner F., Delibaş N., Doĝru H., Sari I., Yorgancigil B. Malondialdehyde levels and superoxide dismutase activity in experimental maxillary sinusitis. Auris Nasus Larynx 1999, 26:287-291.
9. Cross C.E., Halliwell B., Borish E.T., Pryor W.A., Ames B.N., Saul R.L., et al. Oxygen radicals and human disease. Ann Intern Med 1987, 107:526-545.
10. Halliwell B., Gutteridge J.M., Cross C.E. Free radicals, antioxidants, and human disease: where are we now?. J Lab Clin Med 1992, 119:598-620.
11. Buyukhatipoglu H., Sezen Y., Yildiz A., Bas M., Kirhan I., Ulas T., et al. N-acetylcysteine fails to prevent renal dysfunction and oxidative stress after noniodine contrast media administration during percutaneous coronary interventions. Pol Arch Med Wewn 2010, 120:383-389.
12. Buyukhati{dotless}poglu H., Sezen Y., Yildiz A., Guntekin U., Bas M., Polat M., et al. Effects of statin use on total oxidant and antoxidant capacity and ceruloplasmin activity. Clin Invest Med 2010, 33:E313-E320.
13. Percival S.S. Copper and immunity. Am J Clin Nutr 1998, 67:1064-1068.
14. Barber E.F., Cousins R.J. Interleukin-1--stimulated induction of ceruloplasmin synthesis in normal and copper-deficient rats. J Nutr 1988, 118:375-381.
15. Iwata T., Kantarci A., Yagi M., Jackson T., Hasturk H., Kurihara H., et al. Ceruloplasmin induces polymorphonuclear leukocyte priming in localized aggressive periodontitis. J Periodontol 2009, 80:1300-1306.
16. Taysi S., Uslu C., Yilmaz A., Aktan B., Altas E. Lipid peroxidation and some antioxidant enzymes in nasal polyp tissue. Cell Biochem Funct 2006, 24:461-465.
17. Sagit M., Erdamar H., Saka C., Yalcin S., Akin I. Effect of antioxidants on the clinical outcome of patients with nasal polyposis. J Laryngol Otol 2011, 125:811-815.
18. Uneri C., Oztürk O., Polat S., Yüksel M., Haklar G. Determination of reactive oxygen species in nasal polyps. Rhinology 2005, 43:185-189.
19. Cheng Y.K., Hwang G.Y., Lin C.D., Tsai M.H., Tsai S.W., Chang W.C. Altered expression profile of superoxide dismutase isoforms in nasal polyps from nonallergic patients. Laryngoscope 2006, 116:417-422.
20. Cekin E., Ipcioglu O.M., Erkul B.E., Kapucu B., Ozcan O., Cincik H., et al. The association of oxidative stress and nasal polyposis. J Int Med Res 2009, 37:325-330.
21. Cheng Y.K., Tsai M.H., Lin C.D., Hwang G.Y., Hang L.W., Tseng G.C., et al. Oxidative stress in nonallergic nasal polyps associated with bronchial hyperresponsiveness. Allergy 2006, 61:1290-1298.
22. Karlidaĝ T., Ilhan N., Kaygusuz I., Keles E., Yalçin S., Yildiz M., et al. Roles of free radicals, nitric oxide, and scavenging enzymes in nasal polyp development. Ann Otol Rhinol Laryngol 2005, 114:122-126.
23. Dagli M., Eryilmaz A., Besler T., Akmansu H., Acar A., Korkmaz H. Role of free radicals and antioxidants in nasal polyps. Laryngoscope 2004, 114:1200-1203.
24. Okur E., Inanc F., Yildirim I., Kilinc M., Kilic M.A. Malondialdehyde level and adenosine deaminase activity in nasal polyps. Otolaryngol Head Neck Surg 2006, 134:37-40.
25. Giannessi F., Ursino F., Fattori B., Giambelluca M.A., Scavuzzo M.C., Nacci A., et al. Expression of 3-nitrotyrosine, a marker for peroxynitrite, in nasal polyps of nonatopic patients. Med Sci Monit 2010, 16:172-179.
26. Woo H.J., Bae C.H., Song S.Y., Kim Y.W., Lee H.M., Kim Y.D. Expression of glutaredoxin-1 in nasal polyps and airway epithelial cells. Am J Rhinol Allergy 2009, 23:288-293.
27. Bugdayci G., Kaymakci M. Nitrite/nitrate and malondialdehyde levels in nasal polyp. Cell Mol Biol (Noisy-le-grand) 2008, 54:1043-1045.
28. Kang B.H., Huang N.C., Wang H.W. Possible involvement of nitric oxide and peroxynitrite in nasal polyposis. Am J Rhinol 2004, 18:191-196.
29. Erel O. Automated measurement of serum ferroxidase activity. Clin Chem 1998, 44:2313-2319.
30. Dutra F., Ciriolo M.R., Calabrese L., Bechara E.J. Aminoacetone induces oxidative modification to human plasma ceruloplasmin. Chem Res Toxicol 2005, 18:755-760.
31. Blouin C.C., Pagé E.L., Soucy G.M., Richard D.E. Hypoxic gene activation by lipopolysaccharide in macrophages: implication of hypoxia-inducible factor 1alpha. Blood 2004, 103:1124-1130.
32. Mukhopadhyay C.K., Mazumder B. Fox PL. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 2000, 275(28):21048-21054.
33. Martin F., Linden T., Katschinski D.M., Oehme F., Flamme I., Mukhopadhyay C.K., et al. Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation. Blood 2005, 105:4613-4619.
34. Kawano K., Kusunoki T., Ono N., Yao T., Saito T., Yokoi H., et al. Heme oxygenase-1 expression in chronic rhinosinusitis with eosinophilic infiltration. Auris Nasus Larynx 2012, 39:387-392.
35. Takeda K., Takeno S., Hirakawa K., Ishino T. Expression and distribution of glucocorticoid receptor isoforms in eosinophilic chronic rhinosinusitis. Auris Nasus Larynx 2010, 37:700-707.
36. Hafidh M., Harney M., Kane R., Donnelly M., Landers R., Smyth D. The role of fungi in the etiology of chronic rhinosinusitis: a prospective study. Auris Nasus Larynx 2007, 34:185-189.
37. Ikeda K., Yokoi H., Kusunoki T., Saitoh T., Yao T., Kase K., et al. Bacteriology of recurrent exacerbation of postoperative course in chronic rhinosinusitis in relation to asthma. Auris Nasus Larynx 2011, 38:469-473.
38. Morinaka S., Nakamura H. Inflammatory cells in nasal mucosa and nasal polyps. Auris Nasus Larynx 2000, 27:59-64.
39. Sakuma Y., Ishitoya J., Komatsu M., Shiono O., Hirama M., Yamashita Y., et al. New clinical diagnostic criteria for eosinophilic chronic rhinosinusitis. Auris Nasus Larynx 2011, 38:583-588.
40. Ishitoya J., Oguchi N., Wang N.Y., Toriyama M., Kudo K. Clinical characteristics of chronic sinusitis with different lower respiratory tract diseases. Nihon Jibiinkoka Gakkai Kaiho 1996, 99:675-680.
41. Ishitoya J., Sakuma Y., Tsukuda M. Eosinophilic chronic rhinosinusitis in Japan. Allergol Int 2010, 59:239-245.